Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Change in Inventory: 2018-2024

Historic Change in Inventory for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Dec 2024 value amounting to $3.9 million.

  • Catalyst Pharmaceuticals' Change in Inventory rose 353.67% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year decrease of 23.57%. This contributed to the annual value of $3.9 million for FY2024, which is 17.77% down from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Change in Inventory stood at $3.9 million for FY2024, which was down 17.77% from $4.7 million recorded in FY2023.
  • Catalyst Pharmaceuticals' Change in Inventory's 5-year high stood at $4.7 million during FY2023, with a 5-year trough of -$1.1 million in FY2022.
  • Its 3-year average for Change in Inventory is $2.5 million, with a median of $3.9 million in 2024.
  • Its Change in Inventory has fluctuated over the past 5 years, first crashed by 133.08% in 2022, then skyrocketed by 544.98% in 2023.
  • Over the past 5 years, Catalyst Pharmaceuticals' Change in Inventory (Yearly) stood at $2.7 million in 2020, then climbed by 19.49% to $3.2 million in 2021, then tumbled by 133.08% to -$1.1 million in 2022, then surged by 544.98% to $4.7 million in 2023, then declined by 17.77% to $3.9 million in 2024.